Prevalence of pulmonary mycoses in smear-negative patients with suspected tuberculosis in the Brazilian Amazon.

Amazon Amazonia Aspergillosis Aspergilosis Brasil Brazil Criptococosis Cryptococcosis Histoplasmosis Paracoccidioidomicosis Paracoccidioidomycosis Smear-negative tuberculosis Tuberculosis con baciloscopia negativa

Journal

Revista iberoamericana de micologia
ISSN: 2173-9188
Titre abrégé: Rev Iberoam Micol
Pays: Spain
ID NLM: 9425531

Informations de publication

Date de publication:
Historique:
received: 20 02 2020
revised: 02 11 2020
accepted: 11 12 2020
pubmed: 30 3 2021
medline: 29 10 2021
entrez: 29 3 2021
Statut: ppublish

Résumé

Pulmonary mycoses resemble clinically and radiologically chronic pulmonary tuberculosis. Studies describing the prevalence, etiology and clinical features of pulmonary mycosis are of crucial importance in the Brazilian Amazon. To estimate the frequency of pulmonary mycoses in smear-negative tuberculosis patients; to describe their demographic, epidemiological, and clinical characteristics; and to evaluate diagnostic methods. A cross-sectional study was conducted at two tuberculosis reference institutions in Amazonas, Brazil. We included 213 patients and collected clinical data, blood and induced sputum to perform serological, direct microscopy, microbiologic culture and PCR-based assays to identify infections caused by Aspergillus fumigatus, Paracoccidioides brasiliensis, Histoplasma capsulatum, Cryptococcus, and HIV. Chest computed tomography was also performed. Pulmonary mycoses were diagnosed in 7% (15/213) of the cases, comprising ten aspergillosis cases, three cases of paracoccidioidomycosis and one case each of histoplasmosis and cryptococcosis. Among the patients with pulmonary mycoses, 86.7% were former tuberculosis patients. The most significant clinical characteristics associated with pulmonary mycoses were cavity-shaped lung injuries, prolonged chronic cough and hemoptysis. Our study confirmed the high prevalence of pulmonary mycoses in smear-negative tuberculosis patients in the Brazilian Amazon.

Sections du résumé

BACKGROUND BACKGROUND
Pulmonary mycoses resemble clinically and radiologically chronic pulmonary tuberculosis. Studies describing the prevalence, etiology and clinical features of pulmonary mycosis are of crucial importance in the Brazilian Amazon.
AIMS OBJECTIVE
To estimate the frequency of pulmonary mycoses in smear-negative tuberculosis patients; to describe their demographic, epidemiological, and clinical characteristics; and to evaluate diagnostic methods.
METHODS METHODS
A cross-sectional study was conducted at two tuberculosis reference institutions in Amazonas, Brazil. We included 213 patients and collected clinical data, blood and induced sputum to perform serological, direct microscopy, microbiologic culture and PCR-based assays to identify infections caused by Aspergillus fumigatus, Paracoccidioides brasiliensis, Histoplasma capsulatum, Cryptococcus, and HIV. Chest computed tomography was also performed.
RESULTS RESULTS
Pulmonary mycoses were diagnosed in 7% (15/213) of the cases, comprising ten aspergillosis cases, three cases of paracoccidioidomycosis and one case each of histoplasmosis and cryptococcosis. Among the patients with pulmonary mycoses, 86.7% were former tuberculosis patients. The most significant clinical characteristics associated with pulmonary mycoses were cavity-shaped lung injuries, prolonged chronic cough and hemoptysis.
CONCLUSIONS CONCLUSIONS
Our study confirmed the high prevalence of pulmonary mycoses in smear-negative tuberculosis patients in the Brazilian Amazon.

Identifiants

pubmed: 33775537
pii: S1130-1406(21)00007-3
doi: 10.1016/j.riam.2020.12.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-118

Informations de copyright

Copyright © 2021 Asociación Española de Micología. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Joycenea da Silva Matsuda (JDS)

Tropical Medicine Post-Graduate Program - Amazonas State University/Dr. Heitor Vieira Dourado Tropical Medicine Foundation, Manaus, Amazonas, Brazil; Leônidas and Maria Deane Institute [ILMD], Oswaldo Cruz Foundation (FIOCRUZ), Manaus, Amazonas, Brazil; Municipal Health Secretary of Manaus, Amazonas, Brazil.

Bodo Wanke (B)

Mycology Laboratory of the National Institute of Infectious Diseases Evandro Chagas (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.

Antonio Alcirley da Silva Balieiro (AADS)

Leônidas and Maria Deane Institute [ILMD], Oswaldo Cruz Foundation (FIOCRUZ), Manaus, Amazonas, Brazil.

Carla Silvana da Silva Santos (CSDS)

Mycology Laboratory of the Dr. Heitor Vieira Dourado Tropical Medicine Foundation, Manaus, Amazonas, Brazil.

Regia Cristina Dos Santos Cavalcante (RCDS)

Central Laboratory (LACEN), Health Surveillance Foundation of Amazonas State, Manaus, Amazonas, Brazil.

Mauro de Medeiros Muniz (MM)

Mycology Laboratory of the National Institute of Infectious Diseases Evandro Chagas (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.

Daiana Rodrigues Torres (DR)

Mycology Laboratory of the National Research Institute of Amazonia, Manaus (INPA), Amazonas, Brazil.

Silviane Bezerra Pinheiro (SB)

Mycology Laboratory of the National Research Institute of Amazonia, Manaus (INPA), Amazonas, Brazil.

Hagen Frickmann (H)

Department of Tropical Medicine at the Bernhard Nocht Institute, German Armed Forces Hospital of Hamburg, Hamburg, Germany; Institute for Microbiology, Virology and Hygiene, University Medicine Rostock, Rostock, Germany.

João Vicente Braga Souza (JVB)

Tropical Medicine Post-Graduate Program - Amazonas State University/Dr. Heitor Vieira Dourado Tropical Medicine Foundation, Manaus, Amazonas, Brazil; Mycology Laboratory of the National Research Institute of Amazonia, Manaus (INPA), Amazonas, Brazil. Electronic address: joao.souza@inpa.gov.br.

Flor Ernestina Martinez-Espinosa (FE)

Tropical Medicine Post-Graduate Program - Amazonas State University/Dr. Heitor Vieira Dourado Tropical Medicine Foundation, Manaus, Amazonas, Brazil; Leônidas and Maria Deane Institute [ILMD], Oswaldo Cruz Foundation (FIOCRUZ), Manaus, Amazonas, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH